Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2012-04-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diet and Migraine Study
NCT01859052
Nutritional Intervention in Migraine
NCT02703129
Mind Body Intervention for Chronic Migraine Headaches
NCT06690060
Prevalence of Chronic Abdominal Pain in Migraneurs
NCT05086562
Transcriptomic and Biochemical Changes During a Migraine Attack
NCT02468622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Episodic migraineurs
Those with migraines \>2 and \< 12 times per month.
No interventions assigned to this group
Chronic migraineurs
Those with migraines greater than 14 days per month.
No interventions assigned to this group
Controls
Those without headaches other than occasional hangover, cold, flu headaches.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal weight (BMI = 18.5 - 24.9) or obese (BMI ≥ 30)
* Diagnosis of episodic or chronic migraine or pain free control
Exclusion Criteria
* Chronic conditions known to alter risk or pattern of migraine (e.g. hypothyroidism)
* Illnesses that may affect adipokine levels (e.g. diabetes)
* Clinically relevant abnormal glucose/cholesterol levels
* Pregnant women
* Potential participants who are unable to undergo MRI based on standard screening questionnaire (those with brain aneurysm or surgical clips, certain types of artificial heart valves, heart defibrillator or pacemaker, cochlear implants, eye implants, blood vessel coil, recently placed artificial joints, certain types of vascular stents, history of bullets, pellets, BBs, history of any implanted metal or device or who have worked with sheet metal in the past)
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Drs Barbara Peterlin
Director of Headache Research, Johns Hopkins Bayview
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara L Peterlin, DO
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Johns Hopkins Bayview Headache Center
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NA_00051683
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.